The National Safety Council provides information on mental health, workplace safety, and more.
Moderna and Pfizer boosters have been updated to target the omicron variant.
Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.
Drug advancements surrounding the prevention and treatment of COVID-19.
Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.
All adults may now receive a booster shot of any COVID-19 vaccine.
All COVID-19 vaccines now have emergency use authorization for a booster dose.
The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.